UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 88 filers reported holding UNITY BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $29,000 | -31.0% | 74 | 0.0% | 0.00% | – |
| Q2 2022 | $42,000 | -49.4% | 74 | 0.0% | 0.00% | – |
| Q1 2022 | $83,000 | -88.2% | 74 | -84.6% | 0.00% | – |
| Q4 2021 | $704,000 | +166.7% | 482 | +447.7% | 0.00% | – |
| Q3 2021 | $264,000 | -80.8% | 88 | -70.4% | 0.00% | – |
| Q2 2021 | $1,378,000 | -94.9% | 297 | -93.5% | 0.00% | – |
| Q1 2021 | $27,282,000 | -20.5% | 4,547 | -30.6% | 0.00% | – |
| Q4 2020 | $34,327,000 | +25.2% | 6,551 | -17.3% | 0.00% | – |
| Q3 2020 | $27,424,000 | +160.9% | 7,926 | +554.5% | 0.00% | – |
| Q2 2020 | $10,511,000 | -79.6% | 1,211 | -86.4% | 0.00% | – |
| Q1 2020 | $51,463,000 | +111.9% | 8,873 | +163.4% | 0.00% | – |
| Q4 2019 | $24,290,000 | -2.6% | 3,369 | -17.6% | 0.00% | – |
| Q3 2019 | $24,931,000 | -5.8% | 4,087 | +46.6% | 0.00% | – |
| Q2 2019 | $26,476,000 | -39.0% | 2,787 | -48.0% | 0.00% | – |
| Q1 2019 | $43,429,000 | +2868.5% | 5,355 | +5850.0% | 0.00% | – |
| Q4 2018 | $1,463,000 | -45.6% | 90 | -45.5% | 0.00% | – |
| Q3 2018 | $2,688,000 | – | 165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund V Management, LLC | 491,751 | $275,000 | 2.22% |
| GSA CAPITAL PARTNERS LLP | 639,937 | $361,000 | 0.05% |
| PURA VIDA INVESTMENTS, LLC | 359,089 | $202,000 | 0.01% |
| Caption Management, LLC | 725,000 | $409,000 | 0.01% |
| Forefront Analytics, LLC | 20,377 | $11,000 | 0.01% |
| Johnson Midwest Financial, LLC | 6,100 | $3,000 | 0.00% |
| Virtu Financial LLC | 62,640 | $35,000 | 0.00% |
| Caption Management, LLC | 225,000 | $127,000 | 0.00% |
| SeaCrest Wealth Management, LLC | 25,000 | $14,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 191,450 | $108,000 | 0.00% |